Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61974 | CAII-IN-2 | ||
CAII-IN-2 (compound 3g) 是一种硫代氨基脲衍生物。CAII-IN-2是一种有效的选择性碳酸酐酶-II (CA-II) 抑制剂,抑制牛 CA-II 的 IC50为 12.1 μM。CAII-IN-2 在碳酸酐酶相关生物疾病中具有研究价值。 | |||
T61292 | CAII-IN-1 | ||
CAII-IN-1 (compound 3n) is a thiosemicarbazide derivative that acts as a potent and selective inhibitor of carbonic anhydrase-II (CA-II), with an IC50 value of 10.3 μM for bovine CA-II. This compound (CAII-IN-1) finds utility in research pertaining to carbonic anhydrase-associated biological disorders [1]. | |||
T61340 | CAII-IN-3 | ||
CAII-IN-3 (compound 3h) is a thiosemicarbazone derivative known for its potent inhibition of carbonic anhydrase-II (CA-II). It exhibits an IC50 value of 13.4 μM [1]. | |||
T2017 |
U-104
NSC-213841,MST-104 |
Carbonic Anhydrase | Metabolism |
U-104 (NSC-213841) 是 CA IX 和 CA XII 碳酸酐酶 (CA) 抑制剂,其 Ki 分别为 45.1 nM 和 4.5 nM。小鼠模型中,它能够表现出明显的抑制肿瘤生长的作用。 | |||
T73177 |
hCAII-IN-9
|
Carbonic Anhydrase | Metabolism |
hCAII-IN-9 是一种强效的碳酸酐酶抑制剂,对hCA II、hCA IX 和hCA XII 有抑制作用,IC50 分别为 1.18 μM 和 0.17 μM , and 2.99 μM 。hCAII-IN-9 没有血脑屏障透过性。 | |||
T61164 | hCAII-IN-3 | ||
hCAII-IN-3 (Compound 16) is an inhibitor of human carbonic anhydrase (hCA). It exhibits high affinity for hCA I, hCA II, hCA IX, and hCA XII, with Ki values of 403.8 nM, 5.1 nM, 10.2 nM, and 5.2 nM, respectively. Notably, hCA IX-IN-2 demonstrates anticancer activity [1]. | |||
T63631 |
hCAII-IN-2
|
||
hCAII-IN-2 是胞质型人碳酸酐酶 (hCA) 抑制剂,能够作用于 hCA I (Ki: 261.4 nM)、hCA II (Ki: 3.8 nM)、hCA IX (Ki: 19.6 nM)和 hCA XII (Ki: 45.2 nM)。 | |||
T63752 | hCAII-IN-1 | ||
hCAII-IN-1 (compound 7f) 是选择性的、有效的碳酸酐酶 (CA II/IX) 抑制剂,他们的 Kis 值分别为 1.2 和 113.6 nM。hCAII-IN-1 对癌症疾病表现出研究潜力。 | |||
T63805 |
β-Glucuronidase/hCAII-IN-1
|
||
β-Glucuronidase/hCAII-IN-2 (Compound 12e) 是一种有效的β-glucuronidase 和 hCA II 抑制剂,其 IC50分别为 440.1 μM 和 4.91 μM。 | |||
T63789 | β-Glucuronidase/hCAII-IN-2 | ||
β-Glucuronidase/hCAII-IN-2 是 β-glucuronidase 和 hCA II 的有效抑制剂,他们的IC50值分别为 670.7 μM 和 21.77 μM。 | |||
T63467 | hCAII-IN-5 | ||
hCAII-IN-5 (compound 12h),一种对人碳酸酐酶 II (hCA II) 具有选择性的有效抑制剂,IC50值为4.55 μM。 | |||
T74331 | hCAII-IN-7 | ||
hCAII-IN-7 (Compound R-13) 是一种有效的人碳酸酐酶(hCA)抑制剂,对 hCA I、II、IV 和 IX 的 Ki 分别为 60.7、320.7 和 2298 和 35.2 nM。 | |||
T63908 |
hCAII-IN-4
|
||
hCAII-IN-4 (Compound 12j) 是一种有效的hCA II 抑制剂,IC50为 7.78 μM。hCAII-IN-4 也抑制β-glucuronidase,IC50为 773.9 μM。 | |||
T74330 | hCAII-IN-6 | ||
hCAII-IN-6 (Compound S-13) 是一种有效的人碳酸酐酶 II (hCA II) 抑制剂,Ki 为 4.4 nM。hCAII-IN-6 还抑制其他 hCA 同工型 I、IV 和 IX,Ki 值分别为 9.2 nM、480.2 nM 和 14.7 nM, 并可用于青光眼的研究。 | |||
T35713 | N-desethyl Brinzolamide (oxalate) | ||
N-desethyl Brinzolamide is an active metabolite of the carbonic anhydrase (CA) inhibitor brinzolamide .1It inhibits CAII and CAIV activities (IC50s = 1.28 and 128 nM, respectively). 1.Kim, C.-Y., Whittington, D.A., Chang, J.S., et al.Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IVJ. Med. Chem.45(4)888-893(2002) | |||
T37403 | O-desmethyl Brinzolamide (hydrochloride) | ||
O-desmethyl Brinzolamide is an active metabolite of the carbonic anhydrase (CA) inhibitor brinzolamide .1,2It inhibits CAII and CAIV (IC50s = 0.136 and 165 nM, respectively).1 1.Huang, Q., Rui, E.Y., Cobbs, M., et al.Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressureJ. Med. Chem.58(6)2821-2833(2015) 2.Lo Faro, A.F., Tini, A., Gottardi, M., et al.Development and validation of a fast ultra-high-performance liquid chromatography tand... | |||
T61852 |
hCAIX-IN-8
|
||
hCAIX-IN-8 (compound 7i) is a highly potent and selective inhibitor of hCAIX, demonstrating potent inhibitory activity against CAIX with an IC50 value of 0.024 μM. It also exhibits inhibitory activity against CAII and CAVA with IC50 values of 1.99 μM and 1.10 μM, respectively. Furthermore, hCAIX-IN-8 exhibits anti-proliferative effects and low toxicity. It effectively reduces the occurrence of epithelial-to-mesenchymal transitions and promotes apoptosis. Additionally, hCAIX-IN-8 effectively inhi... | |||
T61896 |
hCAIX-IN-12
|
||
hCAIX-IN-12 是有效的hCAIX 抑制剂,抑制 CAIX 和 CAII 的IC50分别为 0.74 和 10.78 μM。hCAIX-IN-12 抗细胞增殖并诱导凋亡 (apoptosis)。hCAIX-IN-12 可以增加ROS 的产生。hCAIX-IN-12在结直肠癌(CRC)中具有研究潜力。 | |||
T36059 |
Dichlorphenamide-13C6
Dichlorphenamide-13C6 |
||
Dichlorphenamide-13C6is intended for use as an internal standard for the quantification of dichlorphenamide by GC- or LC-MS. Dichlorphenamide is a sulfonamide and an orally bioavailable carbonic anhydrase (CA) inhibitor (Kis = 1.20, 38, 50, and 50 nM for the human CA isoforms CAI, CAII, CAIX, and CAXII, respectively).1It lowers intraocular pressure in rabbits when 50 μl of a 10% solution is applied topically to the eye.2Dichlorphenamide rescues the potassium deficiency and prevents insulin-induc... | |||
T35876 |
Chlorthalidone Impurity G
|
||
Chlorthalidone impurity G is a potential impurity found in commercial preparations of chlorthalidone that has moderate antihypertensive effects. Chlorthalidone is a thiazide-like diuretic that inhibits the Na+/Cl- cotransporter in the distal convoluted tubule of the kidney, which prevents reabsorption of sodium and chloride leading to a reduction in plasma volume and cardiac output. It also inhibits carbonic anhydrase (CA), including the isoforms CAVB, VII, IX, XII, and XIII (Kis = 2.8-23 nM) an... |